-
Findings from a just-published study indicate that women who use the contraceptive injection depot medroxyprogesterone acetate (DMPA, marketed as Depo-Provera, Pfizer, New York City) appear to have a threefold increased risk of acquiring chlamydia and gonorrhea when compared to women not using a hormonal contraceptive.
-
The next patient in your exam room is a 16-year-old young woman who says she needs effective contraception. She has tried oral contraceptives (OCs), but she says she has trouble remembering to take a daily pill. What options can you offer her?
-
While the contraceptive transdermal patch (Ortho Evra, Ortho-McNeil Pharmaceutical, Raritan, NJ) and the contraceptive vaginal ring (NuvaRing, Organon, West Orange, NJ) are gaining increased use among women, many providers report that oral contraceptives (OCs) remain a popular form of birth control.
-
-
Take a look at the last 10 patient charts in your outbox. If oral contraceptives (OCs) were prescribed, which ones were selected? When it comes to prescriptions for younger women, about 24% of respondents to the 2004 Contraceptive Technology Update Contraception Survey say their No. 1 pill of choice is Ortho Tri-Cyclen Lo (Ortho-McNeil Pharmaceutical, Raritan, NJ).
-
When it comes to oral contraceptives (OCs), when should pills be prescribed, and when should they be withheld? Respondents to the 2004 Contraceptive Technology Update Contraception Survey take a cautious approach when it comes to providing pills for older women who smoke.
-
When it comes to using combined oral contraceptives (OCs), clinicians and patients look to drug package labeling for the most current information on how the Pill may be safely and effectively used.
-
Is providing emergency contraception (EC) a problem for clinicians in your facility? Since January 2004, eight nurses within the Alabama Department of Public Health system have retired or resigned with letters of resignation that listed dispensing EC as at least one of their reasons for leaving.
-
Rewind to September 1998. Gynétics of Somerville, NJ, introduces the Preven Emergency Contraceptive Kit, the first product for emergency contraception (EC) approved by the Food and Drug Administration (FDA). Now fast-forward six years to the present. The drugs new owner, Barr Pharmaceuticals of Pomona, NY, announces that it will no longer manufacture the product.
-
A just-issued nationwide survey shows that newer reproductive health options such as the contraceptive patch, the contraceptive vaginal ring, and hysteroscopic sterilization are poorly covered by insurance companies when compared to more traditional methods such as the birth control pill.
